CTOs on the Move

Terns Pharmaceuticals

www.ternspharma.com

 
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ternspharma.com
  • 1065 East Hillsdale Boulevard Suite 100
    Foster City, CA USA 94404
  • Phone: 650.275.4395

Executives

Name Title Contact Details

Funding

Terns Pharmaceuticals raised $30M on 04/03/2018
Terns Pharmaceuticals raised $80M on 10/30/2018
Terns Pharmaceuticals raised $87M on 01/05/2021

Similar Companies

International Oncology Network

International Oncology Network is a Frisco, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Paxeon Reconstruction

Allied Digestive Health

Allied Digestive Health is an integrated network of gastroenterology Care Centers. Our multi-specialty group is a dedicated, compassionate team...

Children's Health Council

We understand that mental health needs often increase in times of uncertainty. Concerned? Please reach out. CHC is currently accepting new referrals.

Pharmaprint Inc

Pharmaprint Inc is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.